Re:BioRender – Professional Science Figures
by rudedogg on Friday May 24, 2019 @12:53PM
(#20003356)
> I get why companies are doing this, they want easier cross platform, easier deployability of updates, easier to find devs who know the toolchain, easier to make it work on mobile.
You forgot it justifies having a recurring revenue model, which I'd guess is the main reason :D.
You forgot it justifies having a recurring revenue model, which I'd guess is the main reason :D.